{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:09:18Z","timestamp":1790226558503,"version":"4.1.0"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T00:00:00Z","timestamp":1493683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["RO10AI80737"],"award-info":[{"award-number":["RO10AI80737"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0176660","type":"journal-article","created":{"date-parts":[[2017,5,2]],"date-time":"2017-05-02T13:34:54Z","timestamp":1493732094000},"page":"e0176660","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis"],"prefix":"10.1371","volume":"12","author":[{"given":"Selena","family":"Ferrian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Manca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sugnet","family":"Lubbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Conradie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazir","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilla","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive M.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0362-3345","authenticated-orcid":true,"given":"Dorothy","family":"Fallows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,5,2]]},"reference":[{"key":"ref1","article-title":"Global Tuberculosis Report 2015","year":"2015"},{"issue":"Suppl 3","key":"ref2","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.1093\/cid\/civ612","article-title":"Early Biomarkers and Regulatory Innovation in Multidrug-Resistant Tuberculosis","volume":"61","author":"RS Wallis","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"8","key":"ref3","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1056\/NEJMoa1313865","article-title":"Multidrug-resistant tuberculosis and culture conversion with bedaquiline","volume":"371","author":"AH Diacon","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"ref4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1473-3099(13)70328-1","article-title":"New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects","volume":"14","author":"AI Zumla","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"ref5","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1473-3099(10)70003-7","article-title":"Biomarkers for tuberculosis disease activity, cure, and relapse","volume":"10","author":"RS Wallis","year":"2010","journal-title":"The Lancet Infectious Diseases"},{"issue":"8","key":"ref6","doi-asserted-by":"publisher","first-page":"e71116","DOI":"10.1371\/journal.pone.0071116","article-title":"Month 2 culture status and treatment duration as predictors of tuberculosis relapse risk in a meta-regression model","volume":"8","author":"RS Wallis","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"ref7","doi-asserted-by":"publisher","first-page":"650","DOI":"10.7326\/0003-4819-144-9-200605020-00008","article-title":"Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome","volume":"144","author":"TH Holtz","year":"2006","journal-title":"Annals of internal medicine"},{"issue":"3","key":"ref8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S2213-2600(15)00036-3","article-title":"Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies","volume":"3","author":"EV Kurbatova","year":"2015","journal-title":"The Lancet Respiratory medicine"},{"key":"ref9","article-title":"Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response","author":"R Jacobs","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"ref10","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jinf.2008.02.007","article-title":"Immune parameters as markers of tuberculosis extent of disease and early prediction of anti-tuberculosis chemotherapy response","volume":"56","author":"JF Djoba Siawaya","year":"2008","journal-title":"J Infect"},{"issue":"5","key":"ref11","doi-asserted-by":"publisher","first-page":"e36886","DOI":"10.1371\/journal.pone.0036886","article-title":"Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis","volume":"7","author":"C Riou","year":"2012","journal-title":"PloS one"},{"issue":"3","key":"ref12","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1440-1843.2005.00711.x","article-title":"Levels of tumour necrosis factor-alpha and IL-1alpha in newly diagnosed and multidrug resistant tuberculosis","volume":"10","author":"T Cagatay","year":"2005","journal-title":"Respirology"},{"issue":"6","key":"ref13","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s10096-011-1434-4","article-title":"Characterization of Th1- and Th2-type immune response in human multidrug-resistant tuberculosis","volume":"31","author":"Q Tan","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4049\/jimmunol.158.1.492","article-title":"Patients with multidrug-resistant tuberculosis with low CD4+ T cell counts have impaired Th1 responses","volume":"158","author":"JF McDyer","year":"1997","journal-title":"J Immunol"},{"issue":"10","key":"ref15","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.5588\/ijtld.15.0148","article-title":"Enrichment of regulatory T-cells in blood of patients with multidrug-resistant tuberculosis","volume":"19","author":"N Li","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref16","first-page":"931291","article-title":"The role of foxp3-expressing regulatory T cells and T helpers in immunopathogenesis of multidrug resistant pulmonary tuberculosis","volume":"2012","author":"EG Churina","year":"2012","journal-title":"Tuberc Res Treat"},{"issue":"9","key":"ref17","doi-asserted-by":"publisher","first-page":"e44728","DOI":"10.1371\/journal.pone.0044728","article-title":"Foxp3+ regulatory T cells among tuberculosis patients: impact on prognosis and restoration of antigen specific IFN-gamma producing T cells","volume":"7","author":"A Singh","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"ref18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.tube.2011.02.003","article-title":"Changes in cell-mediated immune response after lung resection surgery for MDR-TB patients","volume":"91","author":"SK Park","year":"2011","journal-title":"Tuberculosis (Edinb)"},{"issue":"7","key":"ref19","doi-asserted-by":"publisher","first-page":"e102178","DOI":"10.1371\/journal.pone.0102178","article-title":"A subset of circulating blood mycobacteria-specific CD4 T cells can predict the time to Mycobacterium tuberculosis sputum culture conversion","volume":"9","author":"C Riou","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"ref20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-2249.2009.03875.x","article-title":"Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis","volume":"156","author":"JF Djoba Siawaya","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"ref21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1365-2249.2006.03211.x","article-title":"Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy","volume":"146","author":"S Brahmbhatt","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"ref22","doi-asserted-by":"publisher","first-page":"e61002","DOI":"10.1371\/journal.pone.0061002","article-title":"Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment","volume":"8","author":"MA De Groote","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"ref23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.tube.2015.04.011","article-title":"Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis","volume":"95","author":"A Jayakumar","year":"2015","journal-title":"Tuberculosis (Edinb)"},{"issue":"12","key":"ref24","doi-asserted-by":"publisher","first-page":"e1001932","DOI":"10.1371\/journal.pmed.1001932","article-title":"Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study","volume":"12","author":"CM Yuen","year":"2015","journal-title":"PLoS Med"},{"issue":"5","key":"ref25","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1172\/JCI77990","article-title":"Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response","volume":"125","author":"T Adekambi","year":"2015","journal-title":"J Clin Invest"},{"issue":"11","key":"ref26","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1631\/jzus.2005.B1045","article-title":"Acute phase reaction and acute phase proteins","volume":"6","author":"E Gruys","year":"2005","journal-title":"J Zhejiang Univ Sci B"},{"issue":"1","key":"ref27","doi-asserted-by":"publisher","first-page":"e15248","DOI":"10.1371\/journal.pone.0015248","article-title":"Performance of serum C-reactive protein as a screening test for smear-negative tuberculosis in an ambulatory high HIV prevalence population","volume":"6","author":"D Wilson","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"ref28","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.5588\/ijtld.11.0743","article-title":"A model to rule out smear-negative tuberculosis among symptomatic HIV patients using C-reactive protein","volume":"16","author":"GG Alvarez","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"ref29","doi-asserted-by":"publisher","first-page":"636","DOI":"10.5588\/ijtld.12.0811","article-title":"Diagnostic and prognostic value of serum C-reactive protein for screening for HIV-associated tuberculosis","volume":"17","author":"SD Lawn","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"981984","DOI":"10.1155\/2013\/981984","article-title":"Differential expression of host biomarkers in saliva and serum samples from individuals with suspected pulmonary tuberculosis","volume":"2013","author":"KG Phalane","year":"2013","journal-title":"Mediators Inflamm"},{"issue":"7","key":"ref31","doi-asserted-by":"publisher","first-page":"e102584","DOI":"10.1371\/journal.pone.0102584","article-title":"Host cytokine responses induced after overnight stimulation with novel M. tuberculosis infection phase-dependent antigens show promise as diagnostic candidates for TB disease","volume":"9","author":"PN Essone","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"ref32","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1378\/chest.50.6.624","article-title":"C-reactive protein in pulmonary tuberculosis","volume":"50","author":"L Haghighi","year":"1966","journal-title":"Dis Chest"},{"issue":"2","key":"ref33","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1183\/09031936.98.12020351","article-title":"Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis","volume":"12","author":"ML Plit","year":"1998","journal-title":"Eur Respir J"},{"issue":"5","key":"ref34","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/IPC.0b013e3181a4c73d","article-title":"Serum C-Reactive Protein in Pulmonary Tuberculosis: Correlation With Bacteriological Load and Extent of Disease","volume":"17","author":"S Rao","year":"2009","journal-title":"Infectious Diseases in Clinical Practice"},{"issue":"2","key":"ref35","first-page":"140","article-title":"C-Reactive Protein in Patients with Pulmonary Tuberculosis","volume":"17","author":"MK Shaikh","year":"2012","journal-title":"World Applied Sciences Journal"},{"issue":"9540","key":"ref36","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S0140-6736(06)69342-2","article-title":"Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum","volume":"368","author":"D Agranoff","year":"2006","journal-title":"Lancet"},{"issue":"5","key":"ref37","first-page":"432","article-title":"Factors associated with time to sputum smear conversion in active pulmonary tuberculosis","volume":"7","author":"A Dominguez-Castellano","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"ref38","first-page":"1010","article-title":"Prognostic value of 'C' reactive protein in tuberculosis","volume":"26","author":"G Bajaj","year":"1989","journal-title":"Indian pediatrics"},{"issue":"3","key":"ref39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.tube.2014.01.006","article-title":"Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis","volume":"94","author":"P Nahid","year":"2014","journal-title":"Tuberculosis (Edinb)"},{"issue":"1","key":"ref40","doi-asserted-by":"publisher","first-page":"e0146318","DOI":"10.1371\/journal.pone.0146318","article-title":"Circulating Angiogenic Factors as Biomarkers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis","volume":"11","author":"NP Kumar","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"ref41","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1378\/chest.125.6.2156","article-title":"Vascular endothelial growth factor levels in active pulmonary tuberculosis","volume":"125","author":"F Alatas","year":"2004","journal-title":"Chest"},{"issue":"2","key":"ref42","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cyto.2009.05.016","article-title":"Differential cytokine\/chemokines and KL-6 profiles in patients with different forms of tuberculosis","volume":"47","author":"JF Djoba Siawaya","year":"2009","journal-title":"Cytokine"},{"issue":"4","key":"ref43","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jinf.2014.10.019","article-title":"Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects","volume":"70","author":"YG Hur","year":"2015","journal-title":"J Infect"},{"issue":"6","key":"ref44","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1073\/pnas.1424563112","article-title":"Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery","volume":"112","author":"M Datta","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"ref45","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1164\/ajrccm.162.3.9911010","article-title":"Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis","volume":"162","author":"W Matsuyama","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"ref46","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jinf.2007.11.004","article-title":"Vascular endothelial growth factor as a marker of disease activity in neurotuberculosis","volume":"56","author":"N Husain","year":"2008","journal-title":"J Infect"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nri3156","article-title":"The role of interleukin-2 during homeostasis and activation of the immune system","volume":"12","author":"O Boyman","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"ref48","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S0962-8479(96)90105-7","article-title":"Correlation of serum interleukin-2 receptor-alpha levels with clinical manifestations in pulmonary tuberculosis","volume":"77","author":"R Rajalingam","year":"1996","journal-title":"Tuber Lung Dis"},{"issue":"1","key":"ref49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/0962935031000096926","article-title":"Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis","volume":"12","author":"L Kart","year":"2003","journal-title":"Mediators Inflamm"},{"issue":"8","key":"ref50","first-page":"720","article-title":"Levels of interferon-gamma and interleukin-2 receptor-alpha for bronchoalveolar lavage fluid and serum were correlated with clinical grade and treatment of pulmonary tuberculosis","volume":"6","author":"TC Tsao","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"ref51","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1183\/09031936.95.08010070","article-title":"Elevated interleukin-2 receptor level in patients with active pulmonary tuberculosis and the changes following anti-tuberculosis chemotherapy","volume":"8","author":"CH Chan","year":"1995","journal-title":"Eur Respir J"},{"issue":"2","key":"ref52","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/0962-8479(95)90555-3","article-title":"Serum soluble interleukin-2 receptor: a useful indicator of the clinical course in pulmonary tuberculosis","volume":"76","author":"MJ Aviles Ingles","year":"1995","journal-title":"Tuber Lung Dis"},{"issue":"2","key":"ref53","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1378\/chest.99.2.310","article-title":"Soluble interleukin-2 receptor in sera of patients with pulmonary tuberculosis","volume":"99","author":"S Takahashi","year":"1991","journal-title":"Chest"},{"issue":"4","key":"ref54","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jinf.2012.11.005","article-title":"Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infection","volume":"66","author":"A Mihret","year":"2013","journal-title":"J Infect"},{"issue":"4","key":"ref55","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jinf.2014.12.019","article-title":"IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy","volume":"70","author":"I Wergeland","year":"2015","journal-title":"J Infect"},{"issue":"4","key":"ref56","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.0818-9641.2004.01245.x","article-title":"Mycobacterium tuberculosis induces high production of nitric oxide in coordination with production of tumour necrosis factor-alpha in patients with fresh active tuberculosis but not in MDR tuberculosis","volume":"82","author":"S Sharma","year":"2004","journal-title":"Immunol Cell Biol"},{"issue":"3","key":"ref57","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1365-2249.2005.02872.x","article-title":"Detection of in vitro interferon-gamma and serum tumour necrosis factor-alpha in multidrug-resistant tuberculosis patients","volume":"141","author":"A Fortes","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"ref58","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.tube.2012.06.005","article-title":"Diagnostic performance of multiplex cytokine and chemokine assay for tuberculosis","volume":"92","author":"X Wang","year":"2012","journal-title":"Tuberculosis (Edinb)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0176660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T07:13:42Z","timestamp":1692774822000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0176660"}},"subtitle":[],"editor":[{"given":"Yoshihiko","family":"Hoshino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,2]]},"references-count":58,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0176660","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,2]]}}}